In June 2022, Marika Nestor’s project aiming to develop a novel cancer therapy left the DDD Platform at SciLifeLab. Six months later, the resulting spin-out company Akiram Therapeutics raised 68 MSEK and is heading for clinical trials in 2024. Read the full SciLifeLab news item here.
Radiopharmaceuticals that fight cancer are on the rise and Marika Nestor is doing everything she can to contribute to their development. An antibody from her lab offers hope for a future treatment for those affected by anaplastic thyroid cancer, a currently incurable form of cancer. Read the full news item from Uppsala University here (in…
A new antibody might be the first effective treatment for Anaplastic thyroid cancer (ATC), a very aggressive cancer type with a median survival of only 4-5 month even with available treatments. The radiolabeled antibody is the result of a four-year long successful collaboration between SciLifeLab researcher Marika Nestor (Uppsala University) and the SciLifeLab Drug Discovery…